Antimetastatic Potential of PAI-1 Specific RNA Aptamers
dc.contributor.author | Blake, Charlene M. | en_US |
dc.contributor.author | Sullenger, Bruce A. | en_US |
dc.contributor.author | Lawrence, Daniel A. | en_US |
dc.contributor.author | Fortenberry, Yolanda M. | en_US |
dc.date.accessioned | 2010-10-14T14:18:48Z | |
dc.date.available | 2010-10-14T14:18:48Z | |
dc.date.issued | 2009-06 | en_US |
dc.identifier.citation | Blake, Charlene M.; Sullenger, Bruce A.; Lawrence, Daniel A.; Fortenberry, Yolanda M. (2009/03/14). "Antimetastatic Potential of PAI-1 Specific RNA Aptamers." Oligonucleotides, 19(2): 117-128 <http://hdl.handle.net/2027.42/78126> | en_US |
dc.identifier.issn | 1545-4576 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/78126 | |
dc.description.abstract | The serine protease inhibitor plasminogen activator inhibitor-1 (PAI-1) is increased in several cancers, including breast, where it is associated with a poor outcome. Metastatic breast cancer has a dismal prognosis, as evidenced by treatment goals that are no longer curative but are largely palliative in nature. PAI-1 competes with integrins and the urokinase plasminogen activator receptor on the surface of breast cancer cells for binding to vitronectin. This results in the detachment of tumor cells from the extracellular matrix, which is critical to the metastatic process. For this reason, we sought to isolate RNA aptamers that disrupt the interaction between PAI-1 and vitronectin. Through utilization of combinatorial chemistry techniques, aptamers have been selected that bind to PAI-1 with high affinity and specificity. We identified two aptamers, WT-15 and SM-20, that disrupt the interactions between PAI-1 and heparin, as well as PAI-1 and vitronectin, without affecting the antiprotease activity of PAI-1. Furthermore, SM-20 prevented the detachment of breast cancer cells (MDA-MB-231) from vitronectin in the presence of PAI-1, resulting in an increase in cellular adhesion. Therefore, the PAI-1 aptamer SM-20 demonstrates therapeutic potential as an antimetastatic agent and could possibly be used as an adjuvant to traditional chemotherapy for breast cancer. | en_US |
dc.format.extent | 442901 bytes | |
dc.format.extent | 3100 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.publisher | Mary Ann Liebert, Inc. | en_US |
dc.title | Antimetastatic Potential of PAI-1 Specific RNA Aptamers | en_US |
dc.type | Article | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.identifier.pmid | 19284310 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/78126/1/oli.2008.0177.pdf | |
dc.identifier.doi | 10.1089/oli.2008.0177 | en_US |
dc.identifier.source | Oligonucleotides | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.